Final analysis of the MAGNOLIA trial: zanubrutinib in marginal zone lymphoma
Final analysis of the MAGNOLIA trial: zanubrutinib in
Final analysis of the MAGNOLIA trial: zanubrutinib in
Clinical findings with sundry targets in various B-cel
Follicular lymphoma: bispecific and PI3Kδ-targeted app
New approaches in relapsed and refractory DLBCL Pol
Latest updates on BTKi-treatment in WM Long-term BT
Emergent BTKi treatments in WM Additionally to ibrut
BTK inhibition in Waldenström’s macroglobulinemia: tri
Management of WM patients previously exposed to BTK-in
Further steps to improve efficacy and safety in acute
Active monotherapies and combinations in mantle cell l